How is the BioAtla Inc today?

The BioAtla Inc today is trading in the green, up by 1.96% at 0.52.

How has BioAtla Inc performed historically?

The BioAtla Inc is currently trading up 1.96% on an intraday basis in the past week the index rose 36.84%. The index has been up 73.33% in the past quarter and fell -67.30% in the past year. You can view this in the overview section.

What is BioAtla Inc Annual Net Profit?

BioAtla Inc Annual Net Profit rose 43.48% in the last year to $69.78 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is BioAtla Inc Price to Earning Ratio?

BioAtla Inc Price to Earning Ratio is -0.49, which is negative.

What is BioAtla Inc Stock Price?

BioAtla Inc Stock Price fell 67.3% and underperformed its sector by 93.8% in the past year.

What is BioAtla Inc Quarterly Net profit?

BioAtla Inc Quarterly Net profit rose 34% YoY to $15.33 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is BioAtla Inc Debt to Equity Ratio?

BioAtla Inc Debt to Equity Ratio of 0.06 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is BioAtla Inc Return on Equity(ROE)?

BioAtla Inc Return on Equity(ROE) for the last financial year was -164.3%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is BioAtla Inc Mutual Fund Holding?

BioAtla Inc Mutual Fund Holding decreased by 0.15% in the last quarter to 9.98.

What is BioAtla Inc Institutional Holding?

BioAtla Inc Institutional Holding decreased by 17.33% in the last quarter to 17.72.

BioAtla Inc XNAS: BCAB

BioAtla Inc Live Share Price Today, Share Analysis and Chart

Name: BioAtla Inc: Is Infosys Ltd. worth buying?
Item: BioAtla Inc
Rating: 1.44766675
Author: Trendlyne DVM scores

about

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbot...

0.52 0.01 (1.96%)

79.37% Fall from 52W High

940.5K XNAS Volume

XNAS 03 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for BioAtla Inc is on 13 Jun 2025 for the purpose of BioAtla Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

19.2 / 100

Technically Neutral

38.7 / 100

1Yr Price target upside is 1502%

3 analysts

BioAtla Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

BioAtla Inc Live Share Price Today, Share Analysis and Chart

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbot...

79.37% Fall from 52W High

SWOT Analysis

BioAtla Inc Live Price Chart

BioAtla Inc FAQ

How is BioAtla Inc today?

BioAtla Inc today is trading in the green, and is up by 1.96% at 0.52.

How has BioAtla Inc performed historically?

BioAtla Inc is currently trading up 1.96% on an intraday basis. In the past week the stock rose 36.84%. stock has been up 73.33% in the past quarter and fell -67.30% in the past year. You can view this in the overview section.